Clinical effect analysis of low dose dopamine and dobutamine subsidiary in treatment of Children serious pneumonia
- VernacularTitle:小剂量多巴胺联合多巴酚丁胺辅助治疗小儿重症肺炎的临床效果分析
- Author:
Cheng WAN
;
Shengyu YAN
;
Gang ZHENG
;
Lingling WEN
;
Kai XU
;
Chunzhen HUA
- Publication Type:Journal Article
- Keywords:
effectiveness analysis;
dopamine;
dobutamine;
Children with severe pneumonia
- From:
Chinese Journal of Biochemical Pharmaceutics
2014;(3):132-134
- CountryChina
- Language:Chinese
-
Abstract:
Objective Clinical effect analysis of low dose dopamine(LDD)and dobutamine (DOB)subsidiary in the treatment of 86 cases of Children serious pneumonia.Methods From July 2011 to July 2013,86 CSP patients who were diagnosed with CSP in People's Hospital of Wenzhou were selected.Patientas were randomly divided into observation group(n=43)and control group(n=43)according to the random number method.Both groups were treated with routine treatment,then observation group on the basis with LDD and DOB subsidiary,then compared efficacy of two groups at 1 week after treatment,as well as the time of symptoms and signs which had improvements,and changes of levels of Interleukin-6(IL-6),Interleukin-8(IL-8), C-reactive protein(CRP)and Tumor necrosis factor-α(TNF-α)before and after treatment. Results The efficacy in observation group was significantly better than that of control group(P<0.05 ).And time of symptoms and signs which had improvement in the observation group was significantly less than control group(P<0.05).After treatment,IL-6,IL-8,CRP and TNF-αlevels were lower than before,but the observation group had a greater degree of reducing(P<0.05).Conclusion Routine treatment combined with LDD and DOB for CSP patients,can significantly improve the therapeutic effect,and relieve the clinical symptoms.
